Walters v. Flint

District Court, E.D. Michigan·Decided December 9, 2021·No. 5:17-cv-10164·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

In re Flint Water Cases Judith E. Levy United States District Judge

__________________________________/

This Order Relates To:

Bellwether I Cases Case No. 17-10164 __________________________________/ OPINION AND ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS VEOLIA NORTH AMERICA, LLC, VEOLIA NORTH AMERICA, INC., AND VEOLIA WATER NORTH AMERICA OPERATING SERVICES, LLC’S MOTION TO EXCLUDE THE TESTIMONY AND REPORT OF DR. WILLIAM BITHONEY [335]

This opinion is the fourth in a series addressing the admissibility of the testimony and reports of eight experts retained by Plaintiffs in anticipation of the first bellwether trial, currently set to begin on February 15, 2022. Defendants argue that none of these experts can meet the standards set by Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). Currently before the Court is the motion by Veolia North America, LLC, Veolia North America, Inc., and Veolia Water North America

Operating Services, LLC (collectively “VNA”) to exclude the testimony and reports of Dr. William Bithoney (ECF No. 335.) The LAN and LAD

Defendants join VNA’s motion. (ECF No. 344.) For the reasons set forth below, VNA’s motion to exclude is GRANTED IN PART and DENIED IN PART.

I. Background Dr. William Bithoney is a medical doctor with over 40 years of experience diagnosing and treating lead exposed children. (ECF No. 436,

PageID.33913-33919). He is currently a consulting physician for the NAACP Lead Poisoning Project in Indiana and the Chief Medical Officer at Ninth Dimension Biotech. (ECF No. 373-2, PageID.24686.) Dr.

Bithoney’s qualifications as an expert are not disputed. Plaintiffs seek to offer Dr. Bithoney as an expert on both general

and specific causation. They retained Dr. Bithoney to determine (1) whether lead-poisoning could cause the adverse health effects they have experienced (general causation), and (2) whether lead-poisoning in fact

did cause those adverse effects (specific causation) in the four bellwether Plaintiffs. Some of Dr. Bithoney’s expected testimony is also relevant to the element of injury. Dr. Bithoney’s opinions as to each element are

summarized below. A. General Causation Opinions

Dr. Bithoney indicates that there is a very strong scientific consensus that exposure to lead, even in very small quantities, can cause

the neurocognitive symptoms experienced by Plaintiffs. Dr. Bithoney first notes that lead exposure can cause decreased

academic achievement. (E.g., ECF No. 330-19, PageID.15042.) That conclusion is primarily based on a study which showed that for every 1 g/dl increase in blood-lead concentration, there was a 0.7 point decrease

in arithmetic scores, a 1 point decrease in reading scores, a 0.1 point decrease in scores on a measure of nonverbal reasoning, and a 0.5 decrease in scores on short-term memory tests. Bruce P. Lanphear et. al.,

Cognitive Deficits Associated with Blood Lead Concentrations <10 mcg/dl in U.S. Children and Adolescents, 115 Public Health Reports 521 (2000) (“Lanphear (2000)”); See also ECF No. 330-19, PageID.15043

(discussing Lanphear study). Dr. Bithoney also considers research that addresses the causal link between overall decrements in intelligence and lead exposure. As early

as the 1990s, studies found that minimal exposures to lead could cause decreases in IQ. A 1994 meta-analysis found with a margin of error of

less than 0.001% that lead poisoning could cause decreases in IQ at blood lead levels as low as 1 g/dl. Joel Schwartz, Low-Level Lead Exposure and Children’s IQ: A Meta-analysis and Search for a Threshold, 65

Environmental Research 42, 53 (1994) (“Schwartz (1994)”). So far, no study has discovered any threshold below which lead does not cause such harms.

Dr. Bithoney testified that he further reviewed the Toxicological Profile for Lead, an exhaustive literature review published by the Agency

for Toxic Substances and Disease Registry (“ATSDR”). (ECF No. 436, PageID.34038-34039.) The Toxicological Profile is one of the most authoritative sources available on the topic of lead poisoning. It, too,

concludes that lead can cause decrements in intelligence at very low levels of exposure. See ATSDR, Toxicological Profile for Lead (Aug. 2020) (https://www.atsdr.cdc.gov/ToxProfiles/tp13.pdf) (“Toxicological Profile”), at 140-176 (reviewing published studies showing a link between lead exposure and decreases in IQ).

Dr. Bithoney next opines that lead exposure can cause neurobehavioral concerns, including attention deficit hyperactivity

disorder (“ADHD”). His report cites to several studies supporting that conclusion. A study by Lisa M. Chiodo reviewed what is known as lead’s

“behavioral signature,” which includes symptoms “in the specific domains of attention, executive function, visual-motor integration, social behavior, and motor skills.” Lisa M. Chiodo et al., Neurodevelopmental

effects of postnatal lead exposure at very low levels, 26 Neurotoxicology and Teratology 3, 359-371, at 359 (2004) (“Chiodo (2004)”). Chiodo concludes that lead poisoning is directly associated with “higher ADHD

and inattention scores…and poorer attention.” Id. at 365. Moreover, according to Chiodo, toddlers exposed to lead “had more difficulties with emotion regulation and behavior orientation.” Id. at 368. Other studies

draw similar conclusions. See, e.g., Joe M. Braun, Exposures to Environmental Toxicants and Attention Deficit Hyperactivity Disorder in U.S. Children, 114 Environmental Health Perspectives 12 (2006) (“Braun (2006)”) (estimating that 290,000 U.S. cases of ADHD are caused by lead exposure).

Dr. Bithoney further mentions that those who are exposed to lead face an increased risk of other health conditions, such as “cardiovascular

disease, hypertension, renal disease, and neurologic deficits.” (ECF No. 330-17, PageID.15015.)

Based on these sources, the Toxicological Profile, and an informational website on the health effects of lead published by the

National Institute of Environmental Health Sciences,1 Dr. Bithoney concludes that any amount of lead in the body can cause neurocognitive harms. (See ECF No. 330-17, PageID.15014.)

B. Specific Causation Testimony Dr. Bithoney then turns to the four individual bellwether Plaintiffs

to consider whether exposure to lead was the cause of their neurocognitive injuries. According to Dr. Bithoney, each of the Plaintiffs’ neurocognitive injuries was likely caused by lead-poisoning.

1 See “Lead and Your Health,” National Institute of Environmental Health Sciences, May 2021, available at https://niehs.nih.gov/health/materials/lead_and_your_health_508.pdf. While COVID-19 prevented Dr. Bithoney from personally examining each Plaintiff, he did conduct thorough interviews with each

of the Plaintiffs’ parents. (ECF No. 436, PageID.33888-33889.) In his deposition, Dr. Bithoney explains that he took a “very extensive history” during those interviews:

I got a social history, where did they live…when did they live

[there], family history, genetic history, history of developmental difficulties in the family members, past medical history, history of hospitalizations, what’s called a

review of systems, headaches, nausea, vomiting, blurred vision, double vision, cough up blood, trouble hearing, trouble seeing, asthma, difficult[y] breathing, gastrointestinal

Free access — add to your briefcase to read the full text and ask questions with AI

Walters v. Flint, (E.D. Mich. 2021).

Walters v. Flint (Walters v. Flint) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Tamraz v. Lincoln Electric Co.
620 F.3d 665 (Sixth Circuit, 2010)
Pluck v. BP Oil Pipeline Co.
640 F.3d 671 (Sixth Circuit, 2011)
Bethie Pride v. Bic Corporation Societe Bic, S.A.
218 F.3d 566 (Sixth Circuit, 2000)
Best v. Lowe's Home Centers, Inc.
563 F.3d 171 (Sixth Circuit, 2009)
In Re Scrap Metal Antitrust Litigation
527 F.3d 517 (Sixth Circuit, 2008)
Polaino v. Bayer Corp.
122 F. Supp. 2d 63 (D. Massachusetts, 2000)
Mark Lee v. Smith & Wesson Corporation
760 F.3d 523 (Sixth Circuit, 2014)
Braylon Seifert v. Kay M. Balink, M.D.
2017 WI 2 (Wisconsin Supreme Court, 2017)
United States v. Lynn Michael LaVictor
848 F.3d 428 (Sixth Circuit, 2017)
Rochkind v. Stevenson
164 A.3d 254 (Court of Appeals of Maryland, 2017)
United States v. Kevin Asher
910 F.3d 854 (Sixth Circuit, 2018)